Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents.
| Image |  |
|---|---|
| Description | scientific article published on 28 May 2018 |
| Author/s |
author: Jose L Jimenez Mauro Gasparini |
| Publication date | May 28, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |